A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19

Br J Hosp Med (Lond). 2020 May 2;81(5):1-2. doi: 10.12968/hmed.2020.0210. Epub 2020 May 18.

Authors

Poornima Kumar¹, Rapti Mediwake², Camilla Rhead³

Affiliations

¹ Department of Clinical Haematology, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
² Department of Rheumatology and General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.
³ Department of General Medicine, Barnet Hospital, Royal Free London NHS Foundation Trust, London, UK.

PMID: 32468942
DOI: 10.12968/hmed.2020.0210

No abstract available

Publication types

Editorial

MeSH terms

Anticoagulants / administration & dosage*
Anticoagulants / adverse effects
Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Drug Administration Schedule
Fondaparinux / administration & dosage
Fondaparinux / adverse effects
Heparin, Low-Molecular-Weight / administration & dosage
Heparin, Low-Molecular-Weight / adverse effects
Humans
Pandemics
Patient Discharge
Pneumonia, Viral / complications*
Risk Factors
SARS-CoV-2
Venous Thromboembolism / etiology*
Venous Thromboembolism / prevention & control*

Substances

Anticoagulants
Heparin, Low-Molecular-Weight
Fondaparinux